ANNE TOLENE: Open Payments
NPI 1447809173 · MOODY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,801 in 95 payments from 16 companies in 2025. Trend: 2023 $1,063 · 2024 $2,080 · 2025 $1,801
Food & beverage: $1,801
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $347 |
| AstraZeneca Pharmaceuticals LP | 12 | $244 |
| GlaxoSmithKline, LLC. | 15 | $240 |
| ABBVIE INC. | 14 | $213 |
| Amgen Inc. | 9 | $200 |
| Otsuka America Pharmaceutical, Inc. | 8 | $145 |
| PFIZER INC. | 5 | $104 |
| Axsome Therapeutics, Inc. | 3 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $43 |
| Exact Sciences Corporation | 2 | $35 |
Products named: TRELEGY ELLIPTA, AIRSUPRA, VRAYLAR, REXULTI, Ozempic, OTEZLA, Wegovy, ELIQUIS.
Industry payments across AL — which companies pay providers there.
